Agen Genomics, Inc.
PrivateLast Round
Seed Round
Aug 28, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Agen Genomics, Inc. operates in Healthcare & Life Sciences and is based in Escondido, California. It was founded in 2025.
Agen Genomics, Inc. is a biotechnology company that provides advanced genetic testing services and personalized health insights for disease prevention and longevity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Sports & Fitness
Business Model
B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agen Genomics, Inc. Comparables
Compare Agen Genomics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Infinite Epigenetics | 84% | |
| TruDiagnostic | 81% | |
| GenoPalate, Inc. | 81% |
For institutional investors. Book with your work email.
Agen Genomics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
$25K seed round completed.
- Mar 3, 2026
Monthly visitors grew 97% MoM.
For institutional investors. Book with your work email.
Agen Genomics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Agen Genomics, Inc.'s valuation, stock price, and market status.
Is Agen Genomics, Inc. a public or private company?
Agen Genomics, Inc. is a private company.
What is the current stock price of Agen Genomics, Inc.?
Agen Genomics, Inc. is a private company, so its shares have no public market price. Caplight tracks Agen Genomics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Agen Genomics, Inc. worth (valuation)?
Valuation information for Agen Genomics, Inc. is not publicly available.
Can I buy Agen Genomics, Inc. stock?
Agen Genomics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Agen Genomics, Inc.'s last funding round?
Agen Genomics, Inc.'s most recent funding round was Seed Round on August 28, 2026.
Who are the main investors in Agen Genomics, Inc.?
Investor information for Agen Genomics, Inc. is not publicly disclosed.
Will Agen Genomics, Inc. IPO soon?
No public IPO plans have been announced for Agen Genomics, Inc..
How can I track Agen Genomics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Agen Genomics, Inc.'s shares on secondary markets.